Cargando…

262. Inhibiting macrophage Warburg effect blocks DNA hyper-methylation and restores immune function

BACKGROUND: Severe and chronic infections, such as sepsis and Tuberculosis (TB), lead to epigenetic-mediated immune suppression. Cancer studies have demonstrated that perturbations in TCA cycle intracellular metabolites trigger global changes in the epigenetic landscape, resulting in immune suppress...

Descripción completa

Detalles Bibliográficos
Autores principales: Abhimanyu, Abhimanyu, Ladki, Malik, Sheikh, Daanish, Nishiguchi, Tomoki, Carrero Longlax, Santiago, DiNardo, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677104/
http://dx.doi.org/10.1093/ofid/ofad500.334
_version_ 1785150051290447872
author Abhimanyu, Abhimanyu
Ladki, Malik
Sheikh, Daanish
Nishiguchi, Tomoki
Carrero Longlax, Santiago
DiNardo, Andrew
author_facet Abhimanyu, Abhimanyu
Ladki, Malik
Sheikh, Daanish
Nishiguchi, Tomoki
Carrero Longlax, Santiago
DiNardo, Andrew
author_sort Abhimanyu, Abhimanyu
collection PubMed
description BACKGROUND: Severe and chronic infections, such as sepsis and Tuberculosis (TB), lead to epigenetic-mediated immune suppression. Cancer studies have demonstrated that perturbations in TCA cycle intracellular metabolites trigger global changes in the epigenetic landscape, resulting in immune suppression that persists after microbial eradication. Therefore inhibiting the TCA cycle may mitigate epigenetic-mediated immune suppression. METHODS: We applied complementary approaches, including data mining public tuberculosis and sepsis datasets, an in vitro LPS-stimulated macrophage tolerance model, DNA methylation (Methyl EPIC), confocal microscopy, and reverse phase protein array (RPPA) to investigate mechanisms of post-infectious immune suppression. Results were validated in tuberculosis patients in a clinical trial using an mTOR inhibitor. RESULTS: Patients with TB and sepsis both demonstrated increased expression of genes involved in glycolysis and the tricarboxylic acid (TCA) cycle, which correlated with an increase in DNA methylation. Human monocytes stimulated with LPS in vitro developed immune tolerance that correlated with DNA hypermethylation. LPS induced the TCA enzymes isocitrate dehydrogenase, citrate synthetase, as well as DNMT3b to translocate into the nucleus. Inhibition of TCA cycle overactivation blocked LPS-induced immune suppression and DNA hyper-methylation. Phase 2 TCA metabolites succinate and itaconate mimicked LPS-induced immune suppression and DNA hyper-methylation. In vitro studies were validated in vivo with TB patients receiving mTOR inhibition (everolimus) having less DNA hyper-methylation. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: TCA cycle activation regulates DNA methylation and immune tolerance. These in vitro and in vivo studies demonstrate that inhibiting the TCA cycle can mitigate epigenetic-mediated immune silencing, potentially identifying a means to prevent post-infectious immune suppression. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10677104
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106771042023-11-27 262. Inhibiting macrophage Warburg effect blocks DNA hyper-methylation and restores immune function Abhimanyu, Abhimanyu Ladki, Malik Sheikh, Daanish Nishiguchi, Tomoki Carrero Longlax, Santiago DiNardo, Andrew Open Forum Infect Dis Abstract BACKGROUND: Severe and chronic infections, such as sepsis and Tuberculosis (TB), lead to epigenetic-mediated immune suppression. Cancer studies have demonstrated that perturbations in TCA cycle intracellular metabolites trigger global changes in the epigenetic landscape, resulting in immune suppression that persists after microbial eradication. Therefore inhibiting the TCA cycle may mitigate epigenetic-mediated immune suppression. METHODS: We applied complementary approaches, including data mining public tuberculosis and sepsis datasets, an in vitro LPS-stimulated macrophage tolerance model, DNA methylation (Methyl EPIC), confocal microscopy, and reverse phase protein array (RPPA) to investigate mechanisms of post-infectious immune suppression. Results were validated in tuberculosis patients in a clinical trial using an mTOR inhibitor. RESULTS: Patients with TB and sepsis both demonstrated increased expression of genes involved in glycolysis and the tricarboxylic acid (TCA) cycle, which correlated with an increase in DNA methylation. Human monocytes stimulated with LPS in vitro developed immune tolerance that correlated with DNA hypermethylation. LPS induced the TCA enzymes isocitrate dehydrogenase, citrate synthetase, as well as DNMT3b to translocate into the nucleus. Inhibition of TCA cycle overactivation blocked LPS-induced immune suppression and DNA hyper-methylation. Phase 2 TCA metabolites succinate and itaconate mimicked LPS-induced immune suppression and DNA hyper-methylation. In vitro studies were validated in vivo with TB patients receiving mTOR inhibition (everolimus) having less DNA hyper-methylation. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: TCA cycle activation regulates DNA methylation and immune tolerance. These in vitro and in vivo studies demonstrate that inhibiting the TCA cycle can mitigate epigenetic-mediated immune silencing, potentially identifying a means to prevent post-infectious immune suppression. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677104/ http://dx.doi.org/10.1093/ofid/ofad500.334 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Abhimanyu, Abhimanyu
Ladki, Malik
Sheikh, Daanish
Nishiguchi, Tomoki
Carrero Longlax, Santiago
DiNardo, Andrew
262. Inhibiting macrophage Warburg effect blocks DNA hyper-methylation and restores immune function
title 262. Inhibiting macrophage Warburg effect blocks DNA hyper-methylation and restores immune function
title_full 262. Inhibiting macrophage Warburg effect blocks DNA hyper-methylation and restores immune function
title_fullStr 262. Inhibiting macrophage Warburg effect blocks DNA hyper-methylation and restores immune function
title_full_unstemmed 262. Inhibiting macrophage Warburg effect blocks DNA hyper-methylation and restores immune function
title_short 262. Inhibiting macrophage Warburg effect blocks DNA hyper-methylation and restores immune function
title_sort 262. inhibiting macrophage warburg effect blocks dna hyper-methylation and restores immune function
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677104/
http://dx.doi.org/10.1093/ofid/ofad500.334
work_keys_str_mv AT abhimanyuabhimanyu 262inhibitingmacrophagewarburgeffectblocksdnahypermethylationandrestoresimmunefunction
AT ladkimalik 262inhibitingmacrophagewarburgeffectblocksdnahypermethylationandrestoresimmunefunction
AT sheikhdaanish 262inhibitingmacrophagewarburgeffectblocksdnahypermethylationandrestoresimmunefunction
AT nishiguchitomoki 262inhibitingmacrophagewarburgeffectblocksdnahypermethylationandrestoresimmunefunction
AT carrerolonglaxsantiago 262inhibitingmacrophagewarburgeffectblocksdnahypermethylationandrestoresimmunefunction
AT dinardoandrew 262inhibitingmacrophagewarburgeffectblocksdnahypermethylationandrestoresimmunefunction